NCT06573099View on ClinicalTrials.gov

A Real-World Study on Extranodal Lymphoma

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2029

Conditions
LymphomaLymphoma, B-CellLymphoma, Non-HodgkinExtranodal LymphomaDiffuse Large B Cell Lymphoma
Interventions
OTHER

No interventions need to be specified for this study

No interventions need to be specified for this study

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT06573099 - A Real-World Study on Extranodal Lymphoma | Biotech Hunter | Biotech Hunter